open access

Vol 74, No 4 (2023)
Clinical vignette
Submitted: 2023-03-07
Accepted: 2023-05-11
Published online: 2023-07-18
Get Citation

Difficulties in achieving euthyroid status in a patient with differentiated thyroid cancer after sleeve gastrectomy

Adam Daniel Durma1, Marek Saracyn1, Anna Celina Durma2, Grzegorz Kamiński1
·
Pubmed: 37578001
·
Endokrynol Pol 2023;74(4):439-440.
Affiliations
  1. Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine — National Research Institute, Warsaw, Poland
  2. Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland

open access

Vol 74, No 4 (2023)
Clinical Vignette
Submitted: 2023-03-07
Accepted: 2023-05-11
Published online: 2023-07-18

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

thyroid cancer; sleeve gastrectomy; liquid levothyroxine

About this article
Title

Difficulties in achieving euthyroid status in a patient with differentiated thyroid cancer after sleeve gastrectomy

Journal

Endokrynologia Polska

Issue

Vol 74, No 4 (2023)

Article type

Clinical vignette

Pages

439-440

Published online

2023-07-18

Page views

756

Article views/downloads

267

DOI

10.5603/EP.a2023.0047

Pubmed

37578001

Bibliographic record

Endokrynol Pol 2023;74(4):439-440.

Keywords

thyroid cancer
sleeve gastrectomy
liquid levothyroxine

Authors

Adam Daniel Durma
Marek Saracyn
Anna Celina Durma
Grzegorz Kamiński

References (5)
  1. Miccoli P, Materazzi G, Rossi L. Levothyroxine Therapy in Thyrodectomized Patients. Front Endocrinol (Lausanne). 2020; 11: 626268.
  2. Jarząb B, Dedecjus M, Lewiński A, et al. Diagnosis and treatment of thyroid cancer in adult patients - Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update [Diagnostyka i leczenie raka tarczycy u chorych dorosłych - Rekomendacje Polskich Towarzystw Naukowych oraz Narodowej Strategii Onkologicznej. Aktualizacja na rok 2022]. Endokrynol Pol. 2022; 73(2): 173–300.
  3. Chacon D, Bernardino T, Geraghty F, et al. Bariatric Surgery With Roux-En-Y Gastric Bypass or Sleeve Gastrectomy for Treatment of Obesity and Comorbidities: Current Evidence and Practice. Cureus. 2022; 14(6): e25762.
  4. Gietka-Czernel M, Hubalewska-Dydejczyk A, Kos-Kudła B, et al. Expert opinion on liquid L-thyroxine usage in hypothyroid patients and new liquid thyroxine formulation - Tirosint SOL [Opinia ekspertów dotycząca stosowania płynnej postaci lewotyroksyny oraz nowego preparatu Tirosint SOL u chorych na niedoczynność tarczycy]. Endokrynol Pol. 2020; 71(5): 441–465.
  5. Yue CS, Scarsi C, Ducharme MP. Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012; 62(12): 631–636.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl